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ABSTRACT 
Oral delivery of gene therapeutics would facilitate treatment of local intestinal 
disease, including colon cancer and inflammatory bowel disease, thus avoiding 
invasive surgery. The aims of this study were to investigate; if the orientation of the 
lipid tail on the cyclodextrin (CD) influenced the efficacy of a novel poly-6-cationic 
amphiphilic CD to transfect intestinal enterocytes; the endocytotic uptake pathway(s), 
and, the intracellular trafficking of the CD.DNA complexes. Inhibitors of clathrin- 
and caveolae- mediated endocytosis and macropinocytosis were used to determine the 
mechanism(s) of CD.DNA uptake by both undifferentiated and differentiated Caco-2 
cells. Cell surface heparan sulphate proteoglycans were involved in the association of 
CD.DNA complexes with undifferentiated Caco-2 cells. Complexation of pDNA with 
CD facilitated significant levels of pDNA uptake and gene expression (comparable to 
PEI) in both undifferentiated and differentiated Caco-2 cells. Disruption of 
intracellular vesicular trafficking reduced transfection activity. CD was also capable 
of transfecting the more physiologically relevant differentiated Caco-2 model. 
Macropinocytosis was responsible for the uptake of CD.DNA transfection complexes 
by both undifferentiated and differentiated Caco-2 cells. The ability of this novel CD 
to transfect differentiated intestinal cells indicates the potential of this vector for oral 
gene delivery. 
 
Keywords: Non-viral gene therapy, cyclodextrins, intestinal delivery, uptake 
pathways, intracellular trafficking. 
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1. INTRODUCTION 
 The intestine is a compelling target for local delivery of gene therapeutics. 
Indeed, the intestinal tract is accessible by oral, rectal, as well as endoscopic means; 
thus avoiding invasive surgery. Local expression of therapeutic proteins may have 
therapeutic benefit in the treatment of inflammatory bowel disease, intestinal cancer, 
and the intestinal symptoms of cystic fibrosis (O' Neill et al. 2011) (Page and 
Cudmore 2001). Furthermore, the intestine can potentially provide a route of entry 
into the bloodstream for locally expressed therapeutic proteins such as Factor VIII in 
haemophilia patients (Bowman et al. 2008), or indeed for gene therapies to distant 
disease sites. 
 However, if the intestinal delivery of gene therapeutics is to be successful, a 
number of distinct challenges must be overcome. While the harsh intestinal 
environment presents a number of distinct extracellular barriers (degradative 
enzymes, mucus), barriers at the cellular level are also significant. Plasmid DNA 
(pDNA) is a high molecular weight, negatively charged, hydrophilic material, which 
is generally poorly taken up by cells. Therefore, the design of gene delivery vectors 
(GDVs) that can effectively complex pDNA and mediate significant levels of cellular 
uptake and transgene expression is key to achieving effective delivery. Cyclodextrins 
(CDs) are macrocyclic oligosaccharides and are interesting core molecules for the 
development of non-viral GDVs. They are non-immunogenic, have well researched 
pharmaceutical profiles, and are chemically versatile in that they can be modified on 
either face with multiple functional groups such as poly(ethylene glycol) (PEG), 
cationic groups, or lipid chains to facilitate optimal pDNA complexation and 
transfection (Cryan et al. 2004) (McMahon et al. 2008). Therefore, a vast library of 
modified CDs with distinctive properties (e.g. neutral, cationic, anionic, amphiphilic) 
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can be synthesised. In addition, the unique inclusion complex forming properties of 
the hydrophobic cavity of CDs can facilitate functionalisation with additional groups 
(e.g. PEG) by non-covalent means if they are conjugated to hydrophobic moieties 
capable of inclusion into the CD cavity (e.g. adamantane-PEG) (Davis 2009). This 
further demonstrates the inherent flexibility associated with using CDs as GDVs. The 
β-CD utilised in this work, the synthesis of which has been described previously 
(Byrne et al. 2009), is modified on its primary face at the 6-positions with cationic 
amino groups and at the 2-positions on its secondary face with lipid chains (Figure 
1b,c). Selective modification of the 2-positions yields CDs with 7 lipid chains, and 
avoids lipid attachment at the 3-positions which would give an excess of 
hydrophobicity and low water solubility (Byrne et al. 2009). The positioning of these 
cationic and lipophilic side chains is the inverse of previous CD based GDVs 
developed by our group (Figure 1a), which were shown to be successful transfection 
agents (Cryan et al. 2004).  
 In terms of cellular targets, the absorptive cells of the intestine, enterocytes, 
represent the major cell type, comprising approximately 90% of the intestinal 
epithelium (Jung et al. 2000). Enterocytes present useful targets for certain gene 
therapy strategies, since, given the underlying rich blood supply, transfected 
enterocytes could be utilised as “protein factories” where the expressed therapeutic 
protein is secreted into the bloodstream (Page and Cudmore 2001). Furthermore, 
locally expressed proteins may have therapeutic potential in the treatment of intestinal 
diseases (e.g. inflammatory bowel disease). The uptake pathway(s) by which 
GDV.DNA complexes enter cells is an important consideration and can have a major 
bearing on transfection efficiency (Douglas et al. 2008). Endocytosis refers to the 
energy dependent vesicular uptake of extracellular material through invagination and 
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pinching off of sections of the plasma membrane; and represents the major entry route 
of GDV.DNA complexes (Khalil et al. 2006). Endocytosis can be classified into 2 
broad categories- phagocytosis and pinocytosis. Pinocytosis can be subdivided further 
into clathrin-mediated endocytosis (CME), caveolae-mediated endocytosis (CvME), 
clathrin- and caveolae-independent endocytosis, and macropinocytosis. These differ 
in terms of the size of vesicles formed, the mechanism of vesicle formation and the 
proteins involved (Khalil et al. 2006). Importantly, the intracellular fate of 
endocytosed complexes differs depending on the route of entry, and therefore the 
uptake pathway can have a major impact on gene expression. The endocytotic 
mechanism(s) by which GDV complexes enter cells depends on both the cell type and 
the physiochemical characteristics of the complexes. Using models of enterocytes 
(such as Caco-2 cells) and other polarised epithelia (such as MDCK cells), a number 
of endocytotic processes have been implicated as uptake pathways for delivery 
systems and nanoparticles in enterocytes (Kitchens et al. 2007) (Ma and Lim 2003) 
(Ragnarsson et al. 2008) (Roger et al. 2009) (Gao et al. 2008). 
Knowledge regarding the means of transfection complex entry can potentially 
allow for more rational design of CDs with increased activity. Therefore, here we 
examine the uptake and transfection of undifferentiated Caco-2 cells (human colon 
carcinoma) by novel water soluble CD.DNA complexes and elucidate the means of 
cellular association and entry. These results are compared to those achieved in 
differentiated Caco-2 cells as the latter represents a more physiological model of gut 
enterocytes. 
 
2. MATERIALS AND METHODS 
2.1. Materials 
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 The poly-6-cationic amphiphilic cyclodextrin (CD) was synthesised as 
previously described (Byrne et al. 2009). Its full name is heptakis[6-(2-amino-
ethylthio)-6-deoxy-2-O-octyloxycarbonylethylsulfanylpropyl]--cyclodextrin hepta-
N-trifluoroacetate. Lipofectamine™ 2000 (Lf2000) and jetPEI™ (PEI) were supplied 
by Invitrogen and Polyplus-transfection, respectively. Caco-2 cells (human colon 
adenocarcinoma) were obtained from the European Collection of Animal Cell 
Cultures (ECACC). Unless otherwise stated all other materials were sourced from 
Sigma. 
 
2.2. Caco-2 cell culture 
Caco-2 cells (passage 26-50) were cultured in DMEM supplemented with 10% 
foetal bovine serum (FBS) and 2 mM L-glutamine, and were maintained in a 
humidified 37
o
C incubator with 5% CO2. For undifferentiated cell studies, cells were 
seeded in 24-well plates at a density of 100,000 cells/cm
2
 24 hours prior to 
transfection. For differentiated cell studies, Caco-2 cells were seeded on 24 or 12 mm 
diameter Transwell™ plates at a density of 63,000 cells/cm2 (Cryan and O'Driscoll 
2003).  Fresh cell culture medium was placed in the apical and basolateral chambers 
every 48 hours, and cells were cultured for 19-21 days to facilitate differentiation.  
 
2.3. Preparation of transfection complexes 
 The pCMVluc plasmid contains the reporter gene that encodes the firefly 
luciferase enzyme under the control of the cytomegalovirus (CMV) 
promoter/enhancer. This was obtained from Bath University, UK. It was propagated 
in DH5α E. coli and isolated using EndoFree Plasmid Mega kits in accordance with 
the manufacturer’s instructions (Qiagen). For uptake studies, pCMVluc was 
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fluorescently labelled with fluorescein using Label IT® Nucleic Acid Labelling Kits 
(Mirus) according to manufacturer’s instructions. A Label IT® Tracker™ Reagent to 
pDNA volume:weight (v:w) ratio of 0.5:1 was used, and the labelling reaction was 
performed for 2 hours at 37
o
C. Unreacted Label IT® reagent was subsequently 
removed from the labelled plasmid by ethanol precipitation. The CD was weighed 
using a microbalance and dissolved in chloroform to create a 1 mg/ml solution. 
Subsequent to this a stream of nitrogen was applied to remove the solvent. The 
remaining CD film was rehydrated with water (1 mg/ml CD solution), followed by 
sonication for size reduction. A solution of pDNA was then mixed with CD to achieve 
a CD:pDNA mass ratio of 10, and 15-20 minutes were  allowed for complexation. PEI 
and Lf2000.DNA transfection complexes were prepared as per manufacturer’s 
instructions. Briefly, PEI.DNA complexes were prepared at a nitrogen/phosphate 
(N/P) ratio of 5 in 150 mM NaCl; while Lf2000 based transfection complexes were 
prepared in serum free Opti-MEM® media (Invitrogen) at a v:w ratio of Lf2000 to 
pDNA of 3. 
 
2.4. Particle size and zeta potential measurement 
 The Z-average size and zeta potential of CD.DNA complexes were determined 
using a Zetasizer Nano ZS instrument (Malvern) at 25
o
C in water. Scattered light was 
measured at an angle of 170
o
 (Z-average size) and 12.8
o
 (zeta potential). 
 
2.5. CD.DNA-Cell binding studies 
 Undifferentiated Caco-2 cells were incubated with fluorescein labelled 
CD.DNA complexes (1 µg pDNA/well) for 1 hour at 4
o
C. Normal serum-containing 
growth medium was added to 0.2% trypsin-0.1% EDTA or 0.1% EDTA treated cells, 
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which were subsequently centrifuged at 1,000 rpm for 7 minutes at room temperature. 
The supernatant was carefully removed and cells were washed and re-suspended in 
phosphate buffered saline (PBS). The fluorescence associated with 10,000 cells was 
measured with a BD FACSCalibur flow cytometer and data was analysed using Cell 
Quest Pro software. 
 To assess the contribution of heparan sulphate proteoglycans to CD.DNA 
binding and uptake, undifferentiated Caco-2 cells were treated for 1 hour at 37
o
C with 
10 unit/ml of heparinase III in a 0.1% bovine serum albumin (BSA), 0.1% glucose, 
PBS solution containing calcium. Cells were subsequently washed and serum free 
DMEM was added along with CD.DNA complexes. The level of CD.DNA binding 
and uptake was assessed 2 hours later. For uptake studies, uninternalised complexes 
were removed prior to trypsinisation by washing cells with PBS (containing Ca
2+
 and 
Mg
2+
) and incubation with CellScrub™ buffer (Genlantis) for 10-15 minutes at room 
temperature. In a separate competition based experiment, soluble heparin (5 and 10 
µg/ml) was included in the transfection media and uptake levels were determined 2 
hours later. 
 
2.6. Uptake and transfection studies 
Fluorescently labelled pDNA complexed with GDVs was incubated with 
undifferentiated Caco-2 cells (1 µg pDNA/well=0.5 µg pDNA/cm
2
) for 1 hour at 4
o
C 
to saturate cell surface binding. Subsequently, cells were incubated at 37
o
C for 0, 
0.25, 1, 2, and 3 hours. Uninternalised complexes were removed with CellScrub™, 
and the number of fluorescent positive cells was assessed by flow cytometry.  
Reporter gene expression levels were considered by luciferase assay. 
Undifferentiated Caco-2 cells were incubated with unlabelled transfection complexes 
 9 
for 1 hour at 4
o
C, and subsequently at 37
o
C for 3 hours. Uninternalised complexes 
were removed, and cells incubated for 24 hours to facilitate maximal luciferase 
expression. 20 µl of cell lysate was added to 100 µl of luciferase assay substrate 
(Promega) and luminescence was measured after 10 seconds using a Junior LB 9059 
luminometer. Luciferase gene expression was expressed in terms of relative light units 
(RLUs)/µg cellular protein as determined using a BCA (bicinchoninic acid) assay as 
per manufacturers instructions (Pierce). For differentiated Caco-2 cells, transfection 
complexes were administered apically (1.28 µg pDNA/cm
2
). Complexes were 
incubated with cells for 4 hours at 37
o
C, after which time cells were rinsed twice with 
serum free DMEM, and incubated for a further 24 hours under normal growth 
conditions to facilitate luciferase expression. For uptake studies, uninternalised 
complexes were removed 4 hours post complex addition with CellScrub™ and pDNA 
uptake was assessed by flow cytometry. 
For endocytosis inhibition experiments, undifferentiated Caco-2 cells were 
pre-treated with a number of inhibitor treatments at concentrations based on literature 
values (Table 1). Inhibition of CME was achieved through hypertonic media and 
cytosol acidification treatments as previously described (Hansen et al. 1993). Cells 
were subsequently incubated in the presence of inhibitor and CD.DNA complexes for 
90 (mβCD, hypertonic media, and cytosol acidification) or 120 minutes (wortmannin, 
LY294002, genistein, chloroquine, and nocodazole) prior to uninternalised complex 
removal with CellScrub™ buffer. The level of uptake was assessed immediately by 
flow cytometry, while luciferase levels were determined 24 hours later. Inhibition of 
macropinocytosis with wortmannin and LY294002 was confirmed by measuring the 
uptake of the macropinocytosis marker, tetramethylrhodamine (TMR)-conjugated 10 
kDa dextran (Invitrogen). Inhibition of CME by hypertonic media and cytosol 
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acidification treatments was ensured by measuring the uptake of AF488 labelled 
transferrin (Invitrogen). 
For endocytosis inhibition experiments in differentiated Caco-2 cells, all 
inhibitor treatments and CD.DNA complexes were applied to the apical compartment.  
Differentiated Caco-2 cells were pre-treated with a number of inhibitors at defined 
concentrations (Table 1) prior to addition of CD.DNA complexes. Cells were 
incubated in the presence of inhibitor and complexes for 4 hours prior to removal of 
uninternalised complexes with CellScrub™ buffer and uptake analysis by flow 
cytometry.  
 
2.7. Toxicity of endocytosis inhibitor treatments 
The toxicity of endocytosis inhibitors was assessed in undifferentiated Caco-2 
cells by MTT assay (Table 1). Caco-2 cells were seeded in 96-well plates at a density 
of 35,000 cells per well (Cryan and O'Driscoll 2003). 24 hours post seeding, cells 
were incubated with the different inhibitors for up to 3 hours, after which time 100 µl 
of normal inhibitor-free growth media was added to cells along with 20 µl of a 5 
mg/ml MTT solution. Samples were incubated for 4 hours at 37
o
C. Subsequently, the 
reaction product was solubilised with 100 µl DMSO and absorbance at 590 nm was 
quantified. The level of cell death was expressed as % dehydrogenase activity relative 
to control cells.  
Differentiated Caco-2 cell monolayer integrity was monitored by recording 
transepithelial electrical resistance (TEER) values immediately (0 hour) and up to 5 
hours post inhibitor addition through the use of a volt/ohmmeter with “chopstick” 
electrodes. Values were expressed as % TEER (Ωcm2) relative to 0 hour TEER 
readings (Table 1). 
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2.8. Confocal microscopy 
Fluorescently labelled CD.DNA complexes (Cy™5 labelled pDNA-Mirus) 
were incubated with undifferentiated Caco-2 cells (grown on round glass coverslips) 
for 3 hours at 37
o
C. Uninternalised complexes were removed with CellScrub™ and 
cells were fixed with 3% paraformaldehyde. Cell nuclei were stained with Hoechst 
dye (Invitrogen) and coverslips were mounted in Dako mounting medium. Images 
were acquired using an Olympus FV 1000 confocal microscope, and processed using 
Olympus Fluoview and Adobe Photoshop/Illustrator software. 
 
2.9. Statistical analysis 
A student’s t-test (two tailed, =0.05) was used to test the significance 
between two mean values. 
 
 
3. RESULTS 
3.1. Poly-6-cationic amphiphilic CD 
 The modified CD used in this study contains amino groups on the primary-
hydroxyl face and lipid chains on the secondary-hydroxyl face (Figure 1b and c). 
Rendering cationic CDs amphiphilic through conjugation of lipid chains has 
previously been shown to increase transfection activity (Cryan et al. 2004) (McMahon 
et al. 2008). This CD was capable of complexing pDNA as assessed by a gel 
retardation assay (data not shown) and formed cationic nanoparticulate complexes 
(154 ± 12 nm; 48.3 ± 5.5 mV) at a CD:pDNA mass ratio of 10 (determined by 
dynamic light scattering measurements). The size and charge of these complexes was 
similar to transfection complexes prepared from previous CDs (Figure 1a) (Cryan et 
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al. 2004) (McMahon et al. 2008) and indicates that the side chain orientation does not 
have a major bearing on the physicochemical characteristics of the complexes. The 
cellular association, uptake and processing of this novel inverted CD were examined 
in an effort to aid design of CD vectors with improved transfection activity. 
 
3.2. Association of CD.DNA complexes with Caco-2 cells 
Caco-2 cells were used for all cell based studies as these are a commonly used 
model of gut enterocytes. To determine if cell surface proteins were involved in 
CD.DNA complex binding to Caco-2 cells, cells were pre-incubated with these 
fluorescent complexes for 1 hour at 4
o
C to saturate cell surface binding, and 
subsequently detached with trypsin-EDTA or EDTA alone, prior to analysis by flow 
cytometry. Trypsin cleaves the protein links by which adherent cells attach to the 
surface of tissue culture plates. However, it also cleaves a range of other membrane 
surface proteins, and therefore complexes associated with trypsin cleavable surface 
proteins. In contrast, EDTA-mediated cell detachment is due to its cation-chelating 
properties and hence complexes associated with surface proteins remain attached to 
the cells. Trypsinisation resulted in a significant drop (P<0.05) in the number of 
fluorescent positive cells of approximately 70% as compared with EDTA-detached 
cells (Table 2) and indicates that CD.DNA binding to Caco-2 cells is mediated by 
trypsin-cleavable cell surface proteins.  
Proteoglycans are a group of cell surface proteins commonly associated with 
non-viral GDV binding to cells (Wiethoff and Middaugh 2003). To examine whether 
heparan sulphate proteoglycans are involved in the binding of CD.DNA complexes to 
Caco-2 cells, Caco-2 cells were pre-treated with the glycosaminoglycan lyase 
heparinase III (Table 2), which specifically cleaves heparan sulphate proteoglycans. 
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Heparinase III treatment resulted in significant drops in both the cellular association 
(80%) and uptake (25%) of CD.DNA complexes (P<0.05) (Table 2). Furthermore, 
inclusion of exogenous soluble heparin in the transfection medium led to significant 
reductions (P<0.05) in CD-mediated pDNA uptake (Table 2) and reporter gene 
expression (data not shown) further supporting the hypothesis of proteoglycan 
involvement in CD.DNA-cell binding. 
 
3.3. Uptake kinetics of transfection complexes in undifferentiated Caco-2 cells 
The uptake kinetics of CD.DNA complexes were compared with those for two 
of the most commonly used GDVs, polyethyleneimine (PEI) and Lipofectamine™ 
2000 (Lf2000) (Figure 2a). CD.DNA uptake was significantly higher than that of the 
other vectors after 0.25 and 1 hour incubations with Caco-2 cells (P<0.05). CD and 
Lf2000 complex uptake was comparable after 2 and 3 hour incubations with Caco-2 
cells, and significantly higher than that observed for PEI.DNA complexes (P<0.05). 
The number of cells positive for CD and Lf2000.DNA complexes was approximately 
5 times higher than that achieved by PEI. The uptake of CD.DNA complexes by 
Caco-2 cells was also confirmed by confocal microscopy (Figure 2b).  
The transfection activity of CD.DNA complexes was compared with that 
mediated by PEI and Lf2000 (Figure 2c). Lf2000 proved the most efficient GDV 
demonstrating approximately 2-fold higher luciferase expression than either PEI or 
CD (P<0.05). Previous CDs with lipid modified primary faces and cationic secondary 
faces achieved comparable transfection levels to the commercial vectors DOTAP and 
Lipofectin (Cryan et al. 2004) (McMahon et al. 2008). Therefore, the similar 
transgene expression levels achieved here relative to PEI indicate that CDs with 
inverted side chain positioning retain their transfection activity. 
 14 
3.4. Endocytosis of CD.DNA complexes by undifferentiated Caco-2 cells 
To assess whether endocytosis and/or passive mechanisms are involved in the 
uptake of CD.DNA complexes, transfection experiments were carried out at 4 and 
37
o
C. CD.DNA uptake and transfection (Figure 3a and b) were reduced by >90% 
when cells were incubated at 4
o
C (P<0.05) indicating that endocytosis was the 
principal route of entry. 
In an effort to elucidate the specific endocytotic uptake pathway(s) utilised by 
CD.DNA complexes in undifferentiated Caco-2 cells, a number of endocytosis 
inhibitor treatments were used (Table 1). The effect of inhibitor treatments on 
CD.DNA uptake was assessed by flow cytometry (Figure 3a). However, given that 
successful uptake does not necessarily translate into successful transgene expression, 
the relationship between the method of CD.DNA uptake and transfection was also 
examined (Figure 3b). Pretreating Caco-2 cells with mβCD resulted in a significant 
drop (P<0.05) in both CD.DNA uptake (~80%) and transfection (>90%) (Figure 3a & 
b). MβCD treatment has been reported to inhibit a range of endocytotic processes 
including CME (Zuhorn et al. 2002) and CvME (Lamaze and Schmid 1995) as well 
as macropinocytosis (Grimmer et al. 2002) and was used here as a general 
endocytosis inhibitor. Both wortmannin and LY294002 treatments resulted in 
significant drops (P<0.05) in the level of CD.DNA uptake (~40%) and transfection 
(~60%). This indicates that macropinocytosis is involved in the uptake and successful 
transfection of CD.DNA complexes by Caco-2 cells. Conflicting results were 
observed post CME inhibition treatments. Treatment with 0.45 M sucrose (hypertonic 
media) resulted in significant drops (P<0.05) in both CD.DNA uptake and 
transfection of ~90%. This suggested that CME may have a major role in CD.DNA 
transfection. However, cytosol acidification treatment did not result in any decrease in 
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the level of CD.DNA uptake or transfection. Indeed, a slight increase in uptake and 
transfection was observed, although this was not statistically significant. Genistein 
treatment led to a significant reduction (P<0.05) in both CD.DNA uptake and 
transfection of approximately 40% (Figure 3a & b) implying a possible role for 
CvME. 
The effects on uptake and transfection are unlikely a result of inhibitor-
induced toxicity since inhibitor treatments were well tolerated by undifferentiated 
Caco-2 cells as assessed by MTT assay, with cell viability levels of >80% (Table 1). 
However, EIPA and filipin were toxic in undifferentiated Caco-2 cells over the 
concentration ranges tested and were not used (Table 1). 
 
3.5. Intracellular trafficking of CD.DNA complexes in undifferentiated Caco-2 
cells 
In addition to assessing the mode of CD.DNA internalisation, the intracellular 
trafficking of CD.DNA complexes was assessed using two pharmacological 
inhibitors, namely chloroquine and nocodazole.  
Chloroquine is a weak hydrophobic base which increases pH in endosomes 
and lysosomes preventing endosomal maturation and subsequent lysosomal 
degradation of genes (Khalil et al. 2006). Although chloroquine is generally believed 
to exert its effect on GDV efficacy by affecting intracellular trafficking, some studies 
have reported that it can also affect particle uptake (Huth et al. 2006). Therefore, the 
impact of chloroquine on CD.DNA entry was assessed (Figure 3a). Chloroquine 
treatment did not significantly affect the level of CD.DNA uptake by undifferentiated 
Caco-2 cells. However, CD-mediated transfection was significantly reduced (P<0.05) 
indicating altered intracellular trafficking (Figure 3b).  
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The microtubule depolymerising agent nocodazole has been used previously 
to assess the involvement of microtubules in the processing of non-viral GDVs by 
cells (van der Aa et al. 2007) (Doyle and Chan 2007). While nocodazole treatment 
had no significant impact on CD.DNA uptake (Figure 3a), luciferase expression was 
reduced by ~60% (Figure 3b) indicating microtubule involvement in the intracellular 
trafficking of complexes. 
 
3.6. Transfection of differentiated Caco-2 cells  
In order to better predict the applicability of CD vectors for intestinal gene 
delivery, a fully differentiated intestinal cell culture model was employed. 
Differentiated Caco-2 cells are used as a model of the small intestinal tract for drug 
transport studies, and more recently in screening GDVs, as they provide a more 
physiologically relevant system than undifferentiated cells. When cultured on semi-
permeable membranes over 18-21 days, Caco-2 cells differentiate to form mature 
enterocyte-like cells complete with tight junctions and apical microvilli (Uduehi et al. 
1999) (Cryan and O'Driscoll 2003).  
CD.DNA demonstrated approximately 50 fold higher transfection than naked 
pDNA alone, and comparable transfection to PEI (Figure 4). Lf2000 was the most 
efficient GDV achieving significantly higher transfection than CD and PEI. This trend 
was similar to that observed for undifferentiated Caco-2 cells (Figure 2c), but with 
much lower levels indicating the increased resistance of differentiated cells to 
transfection. 
 
3.7. Endocytosis of CD.DNA complexes by differentiated Caco-2 cells 
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The decreased activity of GDVs in differentiated Caco-2 cells is believed to be 
due, at least in part, to a decrease in the level of cell association and uptake (Cryan 
and O'Driscoll 2003). This reduction in uptake may also be due to a change in the 
mechanism of particle uptake. To first assess whether CD.DNA uptake by 
differentiated Caco-2 cells is mediated by endocytosis, cells were incubated with 
complexes at 4 or 37
o
C for 4 hours. Uptake was reduced by approximately 80% when 
cells were incubated at 4
o
C (P<0.05) (Figure 5). It should be noted that < 2% of the 
total cell population were positive for CD.DNA uptake in control samples (37
o
C), 
demonstrating the low endocytotic activity of differentiated enterocytes. 
Effects of endocytosis inhibitor treatments were also assessed in differentiated 
Caco-2 cells (Figure 5). Hypertonic media and cytosol acidification treatments were 
again used to inhibit CME. Sucrose at 0.2 M was used in addition to 0.45 M sucrose 
as hypertonic media, since this lower concentration has been used previously with 
differentiated Caco-2 cells (Kitchens et al. 2008) and is less likely to cause toxicity. In 
the literature, the majority of studies use amiloride or its analogs such as EIPA to 
inhibit macropinocytosis in differentiated Caco-2 cells (des Rieux et al. 2007) (Keita 
et al. 2006) (Mathot et al. 2007), and therefore EIPA was the inhibitor of choice for 
differentiated Caco-2 cell studies. Similarly, filipin is the most commonly used 
inhibitor of CvME in differentiated Caco-2 cells (Ma and Lim 2003) (Kitchens et al. 
2008) and was therefore utilised. 
EIPA treatment resulted in a reduction in CD.DNA uptake to background 
levels; and sucrose hypertonic treatments resulted in significant reductions of about 
70%. Cytosol acidification did not significantly affect the level of CD.DNA uptake, 
nor did filipin. These results indicate a role for macropinocytosis and possible roles 
for CME in the uptake of CD.DNA complexes by differentiated Caco-2 cells. 
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To ensure that the observed effects on CD.DNA uptake in differentiated cells 
were not due to inhibitor associated cytotoxic effects, the TEER value of each well 
was recorded during the inhibitor incubation (Table 1). TEER values were 
significantly reduced after incubation with 0.45 M sucrose (~80% drop) and 1 µg/ml 
filipin (~20% drop). Other treatments did not result in significant toxicity, therefore, 
with the exception of 0.45 M sucrose treatment, the observed effects of the inhibitors 
are unlikely due to inhibitor induced toxicity.   
 
3.8. The specificity of CME inhibitors and genistein 
As all macropinocytosis inhibition treatments led to significant reductions in 
CD.DNA uptake in both undifferentiated (wortmannin & LY294002) and 
differentiated (EIPA) Caco-2 cells, it was apparent that macropinocytosis was 
involved in CD.DNA uptake. However, given that hypertonic media and cytosol 
acidification treatments had dissimilar effects on CD.DNA uptake in both 
undifferentiated (Figures 3) and differentiated cells (Figure 5), their specificity as 
CME inhibitors was assessed. To determine whether these treatments were specific 
for CME, their effect on TMR-dextran (macropinocytosis marker) uptake was 
examined in undifferentiated cells, as non-specific inhibition of macropinocytosis 
may explain reduction by hypertonic media treatment. Also given that the CvME 
inhibitor genistein reduced CD.DNA uptake and its specificity has been referred to as 
“doubtful” (Khalil et al. 2006), its effect on TMR-dextran uptake was assessed.  
Treatment with hypertonic media (0.45 M sucrose) resulted in a significant 
decrease (P<0.05) in TMR-dextran uptake of about 80% (Figure 6). In contrast, 
cytosol acidification treatment produced a considerable increase in uptake. This is not 
fully understood but it has been reported that inhibition of endocytotic pathways can 
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lead to induction of compensatory endocytotic processes (Damke et al. 1995), in our 
case possibly an increased level of macropinocytosis. Indeed, an increased level of 
macropinocytosis was believed responsible for the increased uptake of cationic 
particles by HeLa cells upon CME and CvME inhibition (Harush-Frenkel et al. 2007). 
This data explains why a drop in CD.DNA uptake/transfection was observed with 
hypertonic media but not with cytosol acidification treatment (Figure 3 & 5), and 
indicates that CME is not involved in CD.DNA uptake in Caco-2 cells. In addition, 
genistein treatment reduced TMR-dextran uptake (P<0.05) by approximately 60% 
(Figure 6) indicating that CvME may not be involved in CD.DNA uptake. This non-
specific inhibition of macropinocytosis by CME and CvME inhibitors demonstrates 
the importance of ensuring the specificity of inhibitors. 
 
4. DISCUSSION 
The CD gene vector used in these studies is the first successful cationic 
amphiphilic CD-based GDV of this structural class (cationic primary face, lipophilic 
secondary face). It formed cationic nanoparticulate complexes with pDNA and 
retained the ability to transfect relative to CDs of the opposite orientation. The route 
used in its synthesis was high-yielding (Byrne et al. 2009) and provides us with 
increased flexibility in synthesis. These findings highlight the structural flexibility of 
CDs as GDVs and illustrated that attachment of functional groups to the CD core is 
possible on both primary and secondary sides effectively doubling the library of 
modified CDs possible. 
Heparinase III binding and uptake studies helped identify that heparan 
sulphate proteoglycans are responsible for CD.DNA cellular association. As 
proteoglycans are anionic in nature, the interaction between them and the cationic 
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CD.DNA complexes likely occurs largely through ionic interactions. Heparan 
sulphate proteoglycans have been implicated in the binding of a number of viruses, 
cationic polymers (including non-amphiphilic polycationic CDs), and lipids by cells 
(Wiethoff and Middaugh 2003)  (Cryan et al. 2004). In addition, proteoglycans have 
been shown to be cleaved by trypsin treatment of cells (Vogel 1978), explaining the 
decreased level of CD.DNA binding to cells post trypsin treatment. Similarly, 
heparinase treatment of Caco-2 cells has been reported to decrease the level of 
cellular association of chitosan nanoparticles (Behrens et al. 2002). 
The incubation time of GDV.DNA complexes with cells is an important 
parameter that can dictate the level of transfection (Legendre and Szoka 1992) (van 
der Aa et al. 2007). A significant level of CD.DNA uptake was detectable after 15 
minute incubation with undifferentiated Caco-2 cells. This is in agreement with a 
previous study by our group that reported uptake of a cationic amphiphilic CD by 
HepG2 cells within 15 minutes as determined by confocal microscopy (McMahon et 
al. 2008). In our studies, the level of CD.DNA uptake was equivalent to that of 
Lf2000 and significantly higher than that of PEI after 3 hours. Despite this high level 
of uptake, CD-mediated luciferase expression was significantly lower than Lf2000 
and comparable with PEI. Therefore, rapid/high uptake does not necessarily lead to 
high transfection. This is in agreement with Cryan et al. (2004) who reported higher 
levels of non-amphiphilic cationic CD uptake compared with the commercial cationic 
lipid DOTAP but significantly less transgene expression (Cryan et al. 2004). There 
are a number of possible explanations for this phenomenon. It may be that Lf2000 and 
PEI.DNA complexes enter cells by different endocytotic pathway(s) to CD.DNA 
complexes, which are more favourable to transfection. Douglas et al. for example 
reported significant uptake of alginate-chitosan nanoparticles by both 293T and CHO 
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cells (Douglas et al. 2008). Whereas 293T cells were successfully transfected, no 
significant transgene expression was detected in CHO cells. They deduced that CME 
was responsible for uptake by 293T cells while CvME was responsible for uptake by 
CHO cells. Therefore, it is clear that different endocytotic pathways can yield 
different transfection efficiencies.  
Endocytosis is generally considered as the main mechanism of GDV uptake 
by cells (Khalil et al. 2006). In agreement with this we found that CD.DNA 
complexes were taken up by undifferentiated and differentiated Caco-2 cells by 
endocytosis. Inhibitor data indicates that macropinocytosis is the principal endocytotic 
pathway by which CD.DNA complexes enter both undifferentiated and differentiated 
cells. CME inhibition with hypertonic media and cytosol acidification treatments 
however yielded conflicting results. Indeed, our data indicates that the hypertonic 
media induced decrease in CD.DNA uptake was due to non-specific inhibition of 
macropinocytosis. Hypertonic media has been previously reported to inhibit the 
uptake of the fluid phase endocytosis marker horseradish peroxidase (Carpentier et al. 
1989) and a number of other studies have commented on its lack of specificity 
(Perumal et al. 2008). Therefore, CME is unlikely to be involved in the uptake of 
CD.DNA complexes by Caco-2 cells. The CvME inhibitor genistein also inhibited 
TMR-dextran uptake indicating that it was not a selective CvME inhibitor. Indeed, 
genistein’s specificity as a CvME inhibitor has previously been questioned (Khalil et 
al. 2006). The most commonly used CvME inhibitor, filipin, did not significantly 
reduce CD.DNA uptake in differentiated Caco-2 cells. Interestingly, CvME was 
implicated in a recent study in the uptake of poly(amido amine) dendrimers by 
undifferentiated Caco-2 cells (Goldberg et al. 2010). However, in the same study it 
was apparent that CvME was not involved in their uptake by differentiated Caco-2 
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cells. In addition, the expression of the caveolae associated protein, caveolin-1, in 
Caco-2 cells is thought to be quite low. Indeed, some studies have reported that 
caveolin-1 is not expressed in Caco-2 cells and reported little evidence of caveolar 
structures (Vogel et al. 1998) (Lim et al. 2009). However, other studies reported 
detectable levels of caveolin-1 in Caco-2 cells indicating that a low level of 
expression may be present (Field et al. 1998). Notably, when Caco-2 cells were stably 
transfected with caveolin-1, caveolae were only detected in the basolateral membrane 
(Vogel et al. 1998). Similarly, in another model of polarised epithelia, caveolae were 
localised exclusively at the basolateral membrane (Vogel et al. 1998). Therefore, it is 
unlikely that CvME will play a major role in CD.DNA uptake by enterocytes. A 
recent study on the uptake of a highly lipid-modified CD (14 lipid side chains) by 
Vero African green monkey kidney epithelial cells indicated that CME and CvME are 
the major routes of uptake for this particular CD (Diaz-Moscoso et al. 2010). This is 
in contrast to the results obtained in the current study and may be explained by 
structural variations between the CDs and cell type dependent effects. 
Increased transfection may be accomplished by increasing the level of uptake 
by macropinocytosis as has been done in the case of cell penetrating peptides (Wadia 
et al. 2004) (Khalil et al. 2006b). However, our data demonstrates that high uptake 
does not necessitate high levels of transgene expression. Therefore, improving the 
intracellular trafficking properties of CD.DNA complexes is a necessity for future 
success. There is a paucity of data regarding the intracellular trafficking of GDV 
complexes taken up by macropinocytosis. However, the pH of macropinosomes has 
been reported to decrease in cells (Khalil et al. 2006). Indeed, it appears that 
acidification of macropinosomes is necessary for maximal CD.DNA transfection 
given that chloroquine reduced transfection levels. CD.DNA escape may be more 
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efficient at lower pH due to an increase in CD.DNA surface charge, allowing fusion 
with the macropinosomal membrane. Furthermore, inhibition of endosome 
acidification has been reported to inhibit the breakdown of endocytosed heparan 
sulphate proteoglycans by heparinases (Yanagishita and Hascall 1984). Given that 
dissociation of cell penetrating peptides from heparan sulphate is important for their 
endosomal escape (Magzoub et al. 2005), dissociation of CD.DNA complexes from 
heparan sulphate proteoglycans may be necessary for efficient CD.DNA escape from 
macropinosomes. Similarly, Harashima’s group reported that inhibition of 
macropinosome acidification by bafilomcin A treatment reduced transfection by 
octarginine liposomes (El-Sayed et al. 2008). Notably, the authors reported that 
octarginine residues improved the macropinosomal escape of GDVs internalised by 
macropinocytosis and so this approach might improve CD activity by improving 
intracellular trafficking (El-Sayed et al. 2008).  
Our study is among the few that have assessed the impact of differentiation on 
GDV uptake pathways. Low levels of complex uptake in differentiated cells are 
certainly a factor in the reduction in activity of transfection complexes in 
differentiated Caco-2 cells (Cryan and O'Driscoll 2003). Similarly, Boucher’s group 
reported that well differentiated airway cells had reduced levels of lipoplex 
endocytosis relative to poorly differentiated cells (Matsui et al. 1997). Notably, 
heparan sulphate proteoglycans are initially present along the entire surface of 
undifferentiated Caco-2 cells, but during differentiation redistribute to the basolateral 
membrane (Esclatine et al. 2001). Given the presence of tight junctions in 
differentiated Caco-2 cells, it is unlikely that vectors can reach the basolateral 
proteoglycans resulting in a reduction in cell association and uptake via 
proteoglycans. The low levels of transfection in differentiated Caco-2 cells is also 
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likely a consequence of their low mitotic activity (Zauner et al. 1999). The poor 
nuclear accessibility of pDNA in differentiated cells is a significant obstacle and will 
need to be overcome through strategies such as nuclear localisation signal 
conjugation, or the use of siRNAs as alternative therapeutic nucleic acids. 
 
5. CONCLUSIONS 
The means of cellular association and uptake of CD.DNA complexes by Caco-
2 cells were elucidated. Heparan sulphate proteoglycans are responsible for binding of 
complexes to undifferentiated Caco-2 cells, while macropinocytosis is responsible for 
the uptake of CD.DNA complexes by both undifferentiated and differentiated Caco-2 
cells. Microtubules are implicated in the intracellular trafficking of complexes and 
endosomal acidification is necessary for maximal gene expression. This information 
will be used to develop optimised CD based transfection complexes for intestinal 
delivery with enhanced cellular uptake and intracellular trafficking properties. 
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TABLES 
Table 1: Inhibitor concentrations and % cell viability post treatment in 
undifferentiated and differentiated Caco-2 cells as assessed by MTT assay and TEER 
values respectively. Data represents mean ± S.D. (n=3) expressed as a % of control 
values. * indicates statistical significance (P<0.05). 
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Table 2: Involvement of Caco-2 (undifferentiated) cell surface proteins in the binding 
and/or uptake of CD.DNA complexes. 
 
Data represents mean ± S.D. (n=3) relative to control treated cells. All data are 
significantly different to control (100%) values (P<0.05). CD.DNA binding post 
trypsinisation is expressed as a % of EDTA treated cells. Uptake post heparinase III 
and heparin treatment is expressed as a % of cells not incubated with these treatments 
i.e. buffer alone.   
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LEGENDS TO FIGURES 
Figure 1: Amphiphilic cationic cyclodextrins. The CD used in this study has 
structure (c), represented schematically by (b). Previously tested CDs had structure 
(a). 
Figure 2: Uptake of CD.DNA complexes by undifferentiated Caco-2 cells and 
resulting transfection efficiency. a) Uptake kinetics of CD.DNA complexes over 
time compared with PEI and Lf2000. Caco-2 cells were incubated with complexes for 
1 hour at 4
o
C and subsequently at different times at 37
o
C. The level of complex 
uptake was assessed by flow cytometry. Data represents mean ± S.D. (n=4). b) Cells 
were incubated with fluorescent CD.DNA complexes for 3 hours at 37
o
C. 
Uninternalised complexes were removed, and cells were fixed and subsequently 
stained for the nucleus with HOECHST dye, and imaged using a confocal 
microscope. c) Undifferentiated Caco-2 cells were incubated with transfection 
complexes for 1 hour at 4
o
C, and subsequently at 37
o
C for 3 hours. Complexes were 
removed, and cells incubated for 24 hours. Luciferase expression was assessed and 
expressed as RLU/µg protein. Data represents mean ± S.D. (n=3).  
 
Figure 3: Effect of various endocytosis inhibitor treatments on CD.DNA a) 
uptake and b) transfection in Caco-2 cells. Caco-2 cells were pre-treated with 
mβCD (15 minutes), wortmannin, LY294002, genistein (1 hour), hypertonic media 
(30 minutes), and cytosol acidification buffer (10 minutes) for the indicated period of 
time prior to addition of CD.DNA complexes. Cells were incubated in the presence of 
inhibitor and CD.DNA complexes for 90 (mβCD, hypertonic media, and cytosol 
acidification) or 120 minutes (wortmannin, LY294002, and genistein) prior to 
complex removal with CellScrub™ buffer. Uptake was assessed by flow cytometry 
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and expressed as % uptake relative to control (a). Luciferase expression was assessed 
24 hours later and expressed as % RLU/µg protein of control treated cells (b). All data 
represents mean ± S.D. (n=3). * indicates statistical significance relative to control 
treated cells (P<0.05). 
 
Figure 4: Transfection of differentiated Caco-2 cells. Transfection complexes were 
incubated with differentiated Caco-2 cells (day 21) at 37
o
C. Media was removed and 
replaced with serum supplemented DMEM 4 hours later and cells were incubated for 
a further 24 hours. Luciferase expression was assessed and expressed as RLU/µg 
protein. Data represents mean ± S.D. (n=3). 
 
Figure 5: Effect of endocytosis inhibitors on CD.DNA uptake by differentiated 
Caco-2 cells. Differentiated Caco-2 cells were pre-treated with 50 µM EIPA, 1 µg/ml 
filipin (1 hour), 0.2 and 0.45 M sucrose (30 minutes), and cytosol acidification buffer 
(10 minutes) for the indicated period of time prior to addition of CD.DNA complexes. 
Cells were incubated in the presence of inhibitor and CD.DNA complexes for 4 hours 
prior to washing with CellScrub™ buffer and analysis by flow cytometry. Data 
represents mean ± S.D. (n=3) relative to control treated cells (*P<0.05). * indicates 
statistical significance relative to control treated cells (P<0.05). 
 
Figure 6: The effect of hypertonic media, cytosol acidification, and genistein 
treatment on the uptake of TMR-dextran by undifferentiated Caco-2 cells. Cells 
were incubated with inhibitor treatments prior to addition of TMR-dextran (1 mg/ml) 
and the level of dextran uptake was assessed 2 hours later by flow cytometry and 
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expressed as a % of control treated cells. Data represents mean ± S.D. (n=3). * 
indicates statistical significance relative to control treated cells (P<0.05). 
 
Figure 1 
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Figure 2 (c) 
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Figure 3 (b) 
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ABBREVIATIONS 
BCA:   Bicinchoninic acid 
CD:   Cyclodextrin 
CME:   Clathrin mediated endocytosis 
CMV:   Cytomegalovirus 
CvME:  Caveolae mediated endocytosis 
EIPA:   5-(N-ethyl-N-isopropyl)amiloride 
Lf2000:  Lipofectamine™ 2000 
MR:   Mass ratio 
MTT:   3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
N/P:  Nitrogen/Phosphate  
pDNA:  Plasmid DNA 
PEG:  Poly(ethylene glycol) 
PEI:   Polyethylenimine 
RLU:   Relative light units 
S.D.:   Standard deviation 
TMR:   Tetramethylrhodamine 
v:w:   Volume:weight 
